N/A
Completed N=18
PREVENT HPV-Related Cancers - BootCamp Translation
HPV Vaccination · Vaccine; Uptake · Vaccination; Series Completion
Source: ClinicalTrials.gov NCT06290206 ↗
Enrolled (actual)
18
Serious AEs
—
Results posted
May 2025
Primary outcomePrimary: Number of Parents Participating in BCT — 8; 10 Participants
Summary
This study will serve as one of the first to develop and test the effectiveness of strategies to promote HPV vaccination among diverse rural parents and caregivers of children ages 9-17 years in the Mountain West. Once implemented into practice, this intervention could significantly reduce disparities in the burden of HPV-associated cancers among rural populations in the United States.
The proposed study will determine the components of clinic-based outreach to increase vaccination rates for HPV at four community clinics in rural counties in Washington. This study is a boot camp translation to tailor messaging based on patient and provider input.
This study will refine intervention components and messages to increase HPV vaccination among rural children and adolescents (C/A). The research team will use a validated patient-engaged approach for parents/caregivers (P/Cs), Bootcamp Translation (BCT), with separate sessions conducted in English and Spanish.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Parents Participating in BCT |
8; 10 | — |
| SECONDARY Likelihood of Parents to Get the HPV Vaccination for Their Child(Ren) This Year |
6; 1; 1; 5; 0; 1 | — |
| SECONDARY Satisfaction With BCT Session |
9.71; 9.10 | — |
Eligibility Criteria
Inclusion Criteria
- Parents/Caregivers (P/C) of children/adolescents (C/A) ages 9-17 years of age (i.e., age-eligible for HPV vaccination);
- P/C with active clinic patients (i.e., have been seen in the clinic in the last 12 months); and
- P/C who speak either English or Spanish.
Exclusion Criteria
- P/C of C/A with previous excluding HPV vaccination history (e.g., completed vaccination, or not due);
- P/C of C/A with clinical conditions that influence the CDC HPV vaccination recommendations (e.g., pregnancy);
- P/C of C/A with other factors that would influence CDC HPV recommendations; and
- P/C that does not speak Spanish or English.
Data sourced from ClinicalTrials.gov (NCT06290206). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.